Master Manufacturing Record (MMR)
Understand the instructions, evidence and revision controls that connect a manufacturing formula to consistent batch execution.

On this page · 12 sections
- 1What an MMR is—and which rules apply
- 2Drug master records: selected 21 CFR 211.186 requirements
- 3Supplement MMRs: selected contents and control points
- 4Drug master approval: preparation and independent checking
- 5Version control: preserve the master used for each batch
- 6A usable MMR: instructions, limits and linked evidence
- 7Change control: assess, verify and issue
- 8MMR, BMR, BOM and master formula compared
- 9Three worked cases: scale, potency and yield
- 10System handoffs and exception recovery
- 11Eight failure signals and a pre-issue checklist
- 12V5 Ultimate: formula versions and approval snapshots
How does MMR apply to your shop floor?
Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.
01What an MMR is—and which rules apply
A master manufacturing record (MMR) is the written instruction set for a dietary supplement formulation at a defined batch size. 21 CFR 111.205(a) requires manufacturers to prepare and follow a master for each unique formulation and each batch size—not one generic product-family recipe. See dietary supplement CGMP for the surrounding framework.
For drugs, the regulatory term is “master production and control records,” the title of 21 CFR 211.186. Use that terminology when discussing drug CGMP; shared shorthand does not establish shared requirements.
The contents sections below address the respective drug and supplement provisions. The later comparison explains the relationship between the master, BOM, BMR and locally named master formula.
For medicinal products in the EU, EudraLex Volume 4, Chapter 4 provides official guidance for interpreting GMP. It identifies “Manufacturing Formulae, Processing, Packaging and Testing Instructions” as an instruction-document category. Preserve that jurisdictional context when organizing GMP documentation.
In other food and chemical manufacturing, “master formula,” “master recipe” and “MMR” may be local document names rather than these US regulatory terms. As an operating practice, define which controlled documents supply the formulation and process instructions. Keep binding law, official guidance, site practices and software support separately identified: a software field is not the source of a legal obligation.
For device-specific terminology, consult the separate FDA QMSR reference rather than using this drug-and-supplement comparison as a device checklist.
02Drug master records: selected 21 CFR 211.186 requirements
For manufacturers subject to 21 CFR Part 211, 21 CFR 211.186(a) requires master records for each drug product, including each batch size. Preparation and independent checking are addressed in the approval section below.
Identity, formulation and operating instructions
- Product identity: 211.186(b)(1) requires the product name, strength and a description of its dosage form.
- Active-ingredient basis: 211.186(b)(2) requires each active ingredient’s name and weight or measure per dosage unit, or per unit of product weight or measure. It also requires a statement of the total weight or measure of any dosage unit.
- Component identity: 211.186(b)(3) requires a complete component list, using names or codes specific enough to indicate any special quality characteristic.
- Component quantities: 211.186(b)(4) requires an accurate weight or measure for each component, using the same weight system for all components. Reasonable variations may be permitted in component amounts necessary for preparation in the dosage form, provided they are justified in the master production and control records.
- Instructions and controls: 211.186(b)(9) requires complete manufacturing and control instructions, sampling and testing procedures, specifications, special notations and precautions to be followed.
Practical review: reconcile the quantity basis
Product strength describes the declared active amount or concentration; component quantity describes how much material the formula uses; total dosage-unit mass includes active and other formulation material. These are not interchangeable fields. Where applicable, document the basis for a salt-to-base conversion rather than leaving an unexplained numerical adjustment.
Reviewer prompts: Do the master and product specifications use matching strength units? Are quantities stated per dosage unit, per unit of product mass or volume, or per batch? Can the reviewer reconcile these bases without guessing? These are practical dimensional-consistency checks, not additional regulatory requirements.
03Supplement MMRs: selected contents and control points
Identity, overage and yield
Start every supplement master with identity and quantity: 21 CFR 111.210(a) expects the product name plus a stated amount for each dietary ingredient at every batch size the master covers.
21 CFR 111.210(e) requires a statement of any intentional dietary-ingredient overage. 21 CFR 111.210(f) requires theoretical yields at stages where control is needed for quality and the expected finished yield. It also requires maximum and minimum percentages of theoretical yield beyond which a batch deviation investigation, material review and disposition decision are necessary.
Worked example of theoretical versus actual yield, using assumed values: theoretical finished yield 100 kg; MMR limits 95%–102%. An actual yield of 94 kg gives (94 kg ÷ 100 kg) × 100 = 94%, below the assumed minimum. Apply the actions described above.
Packaging and labeling
21 CFR 111.210(g) requires a packaging description and a representative label, or a cross-reference to the physical location of the actual or representative label.
Control points and instructions
21 CFR 111.205(b)(1) requires the MMR to identify control-point specifications; 21 CFR 111.210(h)(1) requires their inclusion in the written instructions. These specifications address supplement quality and packaging and labeling as specified in the MMR.
21 CFR 111.205(b)(2) requires controls and procedures to ensure each batch meets those specifications. The written instructions must also include:
- Sampling procedures and cross-references to test or examination procedures, under 21 CFR 111.210(h)(2).
- Specific actions needed to perform and verify those points, steps or stages, under 21 CFR 111.210(h)(3).
As document-design practice, group each control-point specification with its sampling procedure, test reference and performance or verification actions, so operators need not reconstruct instructions from disconnected sections. This layout is a usability recommendation, not an additional regulatory requirement. Related references: dietary supplement manufacturing controls and in-process specifications and reconciliation.
04Drug master approval: preparation and independent checking
For US drug master production and control records, 21 CFR 211.186(a) requires preparation, dating and signing “(full signature, handwritten)” by one person, and independent checking, dating and signing by a second. It also requires a written preparation procedure that is followed.
Organizational approval is addressed separately: 21 CFR 211.100(a) requires production and process-control procedures, including changes, to be drafted, reviewed and approved by appropriate organizational units, and reviewed and approved by the quality control unit.
Practical review package—not a prescribed departmental workflow: use recipe review and approval to give the independent checker:
- The exact revision under review and its source formulation.
- Component quantities, units and calculation bases, with enough working to independently recalculate totals and conversions.
- Linked manufacturing instructions and the specific revisions reviewed.
- Reviewer questions, responses and resolved discrepancies, including corrections checked before signing.
Record what was examined, not just who signed. A signature meaning statement can distinguish preparation from independent checking. Assess electronic-signature suitability separately rather than inferring it from the handwritten-signature wording alone.
05Version control: preserve the master used for each batch
As a document-control practice, preserve each approved master revision and make changes through a separately approved revision. Supersession changes which revision is available for use; it should not erase the instructions previously issued.
- Current master: the approved, effective revision available for new batch-record issuance within its defined applicability.
- Retained prior revision: the superseded master, recoverable for historical review but not the default for new work.
- Issued batch record: the batch-specific record linked to the master revision assigned at issuance, with execution entries kept distinct from master changes.
Define an effective date and an issuance boundary: which batches will receive the new revision. Before implementation, assess already issued and in-progress batches. Record whether they continue under the assigned revision or require an authorised change; do not silently redirect them to the latest template. Use a recipe supersession log to record the replacement and its scope.
Include formulation, instructions, acceptance criteria, packaging references and execution-relevant linked procedures within the revision boundary. Through document control, retain the applicable versions of referenced documents, or a batch-specific copy of those instructions. A link that always opens the latest procedure does not establish which instructions applied to an earlier batch.
06A usable MMR: instructions, limits and linked evidence
Use the product-specific legal sections above for mandatory contents and terminology. The following is an industry-practice layout for execution and review. Organize the record around the operator’s sequence of work, with supporting methods accessible where needed.
- Scope: product identifier, intended batch size, processing boundaries and responsible operation.
- Quantity basis: component identity, units and the calculation reference for an assay-adjusted charge, where applicable.
- Sequence: ordered actions, preparation prerequisites, equipment or setup references and applicable parameters.
- Control points: observation or sample location, timing, method identifier, acceptance criterion and evidence field for each in-process control.
- Dependencies: linked preparation, handling or cleaning instructions needed before the next operation can begin.
- Exceptions: what stops, whom the operator contacts and how affected material is identified.
For each instruction, specify the action, applicable limit, evidence to capture and exception response. Avoid “mix adequately” unless a controlled method supplies the detail. A target is the intended value; an acceptance interval defines permitted bounds; a result records what occurred. Assuming an illustrative temperature-controlled step, record the 60 °C target, 58–62 °C acceptance interval and 59.4 °C result separately.
For a timed mixing step, specify what starts the clock: completion of addition, achievement of a stated speed or another defined event. State how an interruption is handled and whether elapsed time means continuous or cumulative mixing. “Mix for ten minutes” leaves these questions unanswered. Select process values from the site’s technical basis; illustrative values are not manufacturing recommendations.
For medicinal products, EU GMP Chapter 4, paragraph 4.4 recommends orderly, easily checked instructions whose style and language fit their intended use. Put a precaution before the action it affects, rather than after the operator has completed it.
Chapter 4, paragraph 4.10 also says to define which record relates to each manufacturing activity and where it is located. Practically, use production context tagging to connect batch, step, component or sample identifiers to retrievable evidence in the batch execution history.
For sampling, name the location and stage represented; a field labelled only “sample taken” can leave that context unclear. Give the sample identifier a defined place beside the collection details so reviewers can connect the result to the intended control.
Master Revision
Defines controlled instructions and their product-and-size scope.
- master_revision_id
- product_id
- batch_size
- batch_size_uom
- status
Component Line
Connects material identity, quantity basis and tolerance.
- component_id
- item_id
- quantity
- unit_of_measure
- quantity_basis
- tolerance_pct
Process Step
Connects ordered work to measurable acceptance criteria.
- step_id
- sequence
- instruction_ref
- parameter_limits
- acceptance_criteria
Approval Event
Identifies the reviewed revision, person, decision and time.
- approval_id
- master_revision_id
- reviewer_id
- decision
- signed_at
Batch Execution
Links actual lots and results to issued instructions.
- batch_id
- master_revision_id
- material_lot_ids
- actual_quantities
- result_refs
07Change control: assess, verify and issue
Use this change-control lifecycle as recommended practice, not a universal regulatory approval route. Apply the revision-preservation and transition principles covered above; this workflow addresses the technical justification and implementation work needed to make a change usable.
- Define the reason and intended result: identify the affected master, supporting evidence and what the change is expected to correct.
- Assess dependencies: trace effects through component quantities, equipment, instructions, specifications, calculations and downstream templates. Identify any necessary process validation or other technical checks.
- Prepare a traceable proposal: connect each changed field or instruction to the reason and impact assessment. Include affected linked documents in the review package.
- Review the technical basis: record the selected checks, acceptance criteria, results and approval decisions. Distinguish completed evidence from work still outstanding.
- Demonstrate readiness: check affected forms and interfaces, and confirm that required instruction or training is completed and recorded in the relevant training record.
- Close with evidence: record implementation completion and define any follow-up review needed to establish whether the change addressed its original purpose.
Assume a proposed change replaces a mixer with a larger vessel but leaves nominal batch mass unchanged. The impact assessment should address working volume, mixing regime, addition access, sample locations and cleaning instructions. Matching batch mass does not establish equivalent process performance. Record which checks are needed and who will evaluate the results; do not settle adequacy by copying the old mixing time.
For US drug products subject to Part 211, 21 CFR 211.180(e) requires records to support evaluation, at least annually, of each drug product’s quality standards to determine whether specifications or manufacturing or control procedures need changes. This annual product review can inform a master-record change; the annual obligation is evaluation, not mandatory revision of every master.
The evaluation includes a representative number of batches, whether approved or rejected, and associated records where applicable under 211.180(e)(1). It also includes complaints, recalls, returned or salvaged drug products and investigations conducted under § 211.192, as specified in 211.180(e)(2).
Translate findings into a specific change question. Repeated clarification requests may justify reviewing instruction wording; they do not, by themselves, establish that a process parameter should change.
- Define scopeIdentify product, formulation, batch size and applicable requirements.
- Draft InstructionsSet quantities, operations, limits and referenced procedures.
- Review contentCheck completeness and apply any independent-check requirement.
- Approve revisionRecord decisions and establish the revision's applicability.
- Issue BatchAssociate the batch with its controlled instruction revision.
- Capture executionRecord actual materials, results and documented exceptions.
- Review and improveAssess evidence and route justified changes for review.
08MMR, BMR, BOM and master formula compared
For dietary supplements, 21 CFR 111.205(c) requires making and keeping master manufacturing records in accordance with subpart P. The table places the masters discussed above alongside related documents; it compares functions, not interchangeable regulatory requirements.
| Term | Main purpose | Level | What it does not establish alone |
|---|---|---|---|
| Master manufacturing record (MMR; dietary supplements) | Supply the supplement instructions and controls described above | Master | Actual batch execution |
| Master production and control record (drugs) | Supply the drug production and control baseline described above | Master | Completion of batch operations |
| Batch manufacturing or production record | Document execution for an individual batch | Batch-specific | Adequacy of the underlying master |
| Bill of materials (BOM) | List material identities and quantities | Usually master | Full operating instructions or execution evidence |
| Master formula | Describe formulation; document boundaries vary locally | Usually master | Equivalent scope to a complete MMR |
| Master batch record | Provide a reusable batch-record template; usage varies locally | Usually master | A completed batch history |
For drugs, 21 CFR 211.188(a) requires an accurate reproduction of the appropriate master production or control record, checked for accuracy, dated and signed. Separately, 21 CFR 211.188(b) requires documentation that each significant manufacturing, processing, packing or holding step was accomplished. Copying instructions supplies the starting document, not evidence that the work occurred.
In practice, connect BOM entries to controlled material master data and keep master formula revision history identifiable. When transferring documents, map materials to their consuming operations and locate the associated controls and execution fields; matching titles is insufficient.
09Three worked cases: scale, potency and yield
These hypothetical cases illustrate calculation and review practice, not validated manufacturing instructions. Each makes the quantity basis explicit so the reviewer can reproduce the result.
Case 1: Proportional scaling
Assume a 100 kg blend contains 5 kg ingredient A, 20 kg ingredient B and 75 kg carrier. All quantities are as-received masses, with no additional loss allowance. For a 250 kg batch, the scaling factor is 250 ÷ 100 = 2.5.
The scaled charges are 12.5 kg A, 50 kg B and 187.5 kg carrier: 12.5 + 50 + 187.5 = 250 kg. Apply the batch-size scope covered above. Correct material scaling does not establish suitable mixing time, equipment loading or process settings; those need separate assessment.
Case 2: Potency adjustment
Assume a 100 kg blend needs 12 kg active equivalent. The input ingredient assays at 96% w/w on an as-received basis; the adjustable carrier contributes no active. An assessed and approved instruction permits this adjustment. No separate moisture correction, overage or process loss is assumed.
Master calculation rule: ingredient mass = required active-equivalent mass ÷ assay expressed as a mass fraction; carrier mass = target blend mass − ingredient mass. Keep the potency basis and correction factor explicit: here, 96% means 0.96 kg active equivalent per kg of ingredient.
Execution evidence: record the lot-specific assay and actual dispensed quantities separately from that master rule. With this lot, required ingredient is 12 ÷ 0.96 = 12.5 kg; active equivalent is 12.5 × 0.96 = 12 kg; carrier is 100 − 12.5 = 87.5 kg. The calculated charge is not itself evidence of what was dispensed.
Case 3: Yield evaluation
Assume theoretical recovered blend mass is 200 kg, actual recovered mass is 194 kg and the predefined acceptance interval is 96%–99%. The theoretical-versus-actual yield calculation is 194 ÷ 200 × 100 = 97%, inside the interval. A 190 kg recovery gives 190 ÷ 200 × 100 = 95%, outside it.
These limits are illustrative, not regulatory defaults. This calculation evaluates only the yield criterion, not overall batch acceptability. An out-of-range result enters the site's exception process; changing the theoretical basis to conceal it defeats the comparison.
10System handoffs and exception recovery
Integration-design practice assigns clear ownership to each handoff: planning supplies product, order and quantity; the controlled master supplies instructions; execution returns material usage and step evidence; laboratory references identify the sample tested. Connect these records through identifiers rather than matching names.
For MES–QMS integration, define the authoritative system for each field, expected units, required identifiers and the meaning of an acknowledgement. Distinguish receipt of a message from successful creation of a complete, usable record. Define how a rejected field or component line is reported.
For medicinal products, EU GMP Chapter 4, paragraph 4.1 calls for stated relationships and controls for master documents, official copies, data handling and records in hybrid and homogeneous systems. Map these relationships when designing a hybrid record system.
Assume a sender transfers one production order and times out before acknowledgement. The receiver may have created the order despite the missing response. A blind resend could create a second order; clearing the sender’s error does not establish the receiving system’s state.
- Isolate the affected transfer and prevent uncertain or duplicate records from being used downstream.
- Query the receiver using the original transaction and order identifiers; establish whether it committed all, part or none of the transfer.
- Compare required fields, component-line counts, quantities and units with the authoritative sending record.
- Reconcile partial updates and duplicates before retrying. Keep a stable identifier that allows the receiver to recognize a repeated request.
- Record the correction and its authorization, then verify the receiving record and any downstream material-consumption posting.
A retry should not post material usage again merely because a response was lost. If the receiver cannot safely accept a retry, use an authorized reconciliation path instead of repeated resubmission. Recovery is complete when records reconcile, not merely when an error message disappears.
Recovery testing should also cover a duplicate response, a rejected component line and an interrupted correction. Define the expected receiving state for each case before testing, including which records should exist and which downstream actions should remain blocked.
11Eight failure signals and a pre-issue checklist
Use these industry-practice checks before issuing a master for batch use. A failure signal is not itself a finding of noncompliance; assess product scope, facts and applicable requirements.
| Failure signal | Reviewer test |
|---|---|
| Product or batch-size mismatch | Match the product and intended batch size to the document being issued, not just its filename. |
| Instruction references cannot be followed | Open each essential reference from the operator’s working location and find the relevant instruction. |
| Unexplained manual arithmetic | Recalculate a selected addition from the stated inputs, units and calculation basis. |
| Blank fields have no defined meaning | Check that not applicable, not performed and a measured zero cannot be confused. |
| Hold point lacks an escalation route | Identify the responsible decision-maker and where the outcome is recorded. |
| Rendering changes the instruction | Check decimal points, units, symbols, table continuations and instructions split across pages. |
| Issued record cannot be retrieved | Retrieve a selected batch’s master and its supersession history, using the controls covered above. |
| Transfer discrepancy remains unresolved | Use the recovery checks above; do not accept a cleared interface alert as closure evidence. |
For medicinal products, EU GMP Chapter 4, paragraph 4.2 says reproduction of working documents from masters should not introduce errors. A practical check therefore examines the issued print or export, not only the authoring view: a correct source can still produce an incomplete working copy.
Pre-issue review sequence
- Record the exact document or template reviewed and the view used: workstation display, issued print or exported file.
- Log each finding against a step or field, state the expected wording or behavior and assign an owner.
- Assess whether the finding prevents correct execution, changes a calculation or affects presentation; document its disposition before issue.
- Recheck the correction in the output operators will use, retaining closure evidence with the recipe review and approval record.
If a defect is found after use, capture affected batch identifiers in a deviation assessment rather than assuming a corrected template resolves prior execution. Determine whether the defect affected legibility alone or could have changed ingredient quantities, step completion or interpretation of results.
Assess recurring defects for systemic investigation and corrective and preventive action (CAPA). Repeated unit omissions, for example, may warrant reviewing the template and authoring checks; not every isolated document correction needs CAPA.
12V5 Ultimate: formula versions and approval snapshots
Frequently asked questions
Q.If only the bottle count or label changes, what should be assessed before revising a dietary-supplement MMR?+
See “Supplement MMRs: selected contents and control points” for packaging content. For the change assessment, identify whether “bottle count” means units per container or containers per batch. Then check effects on component quantities, label claims, coding, line settings, sampling and reconciliation. If container size or closure changes, include a stability assessment. Record which master instructions and linked documents need revision, with a reason for any items judged unaffected.
Q.What should a brand owner and contract manufacturer agree about access to the master and its revision history?+
In the agreement with a contract manufacturer, define record ownership, authorized requesters, confidentiality safeguards and response times for investigations or recalls. Specify export formats, escalation contacts, retrieval responsibilities and access after termination or a system change. Use the historical-record scope in the version-control section rather than treating the latest PDF as sufficient. As a practical acceptance check, test whether an authorized requester can retrieve a complete example record package.
Q.Is a master approved at one manufacturing site ready to use at another site?+
Not on approval alone. As a practical transfer assessment, compare receiving-site equipment geometry, working volumes, material grades, utilities, sampling arrangements and operator preparation. Identical mixer speeds do not establish equivalent mixing in different vessels. Ask for evidence that the specified operating ranges and checks are suitable locally, including relevant process validation results. Use “A usable MMR: instructions, limits and linked evidence” to organize the review, and resolve site-specific instruction gaps before issuing the master for use.
Q.Can a spreadsheet serve as the master, and what should happen when approved paper and electronic copies disagree?+
Potentially. Where Part 11 applies, 21 CFR 11.1(d) permits electronic records meeting its requirements to replace paper in accordance with § 11.2, unless paper is specifically required. As practical checks, assess content, formula protection, access, approval, revision identification, printing and retrieval. If approved copies disagree, pause affected work, preserve both, establish authorized instructions and assess batches already affected. Define copy authority through document control; do not choose by file date alone.
Q.When ingredient potency changes between lots, which values belong in the master and which belong in the batch record?+
Use “MMR, BMR, BOM and master formula compared” for the record split and “Three worked cases: scale, potency and yield” for the calculation. For review, trace one assay-adjusted charge from the accepted lot assay through the authorized equation to the actual weighed amount. Check assay basis, units, rounding and adjustment limits. A dry-basis assay should not enter an as-received calculation without the specified conversion. Escalate missing inputs or out-of-range adjustments rather than editing the formula locally.
Q.What evidence should reviewers request after masters are migrated to a new document or manufacturing system?+
Request a source-to-target inventory, approved field mappings, discrepancy resolutions and documented acceptance results. Use requirements traceability to connect migration risks to tests. Challenge decimal precision, units, component order, equations, limits and referenced instructions; for executable masters, test calculations and branching rather than comparing screenshots alone. Include rejected imports and partially transferred records in the test set. Apply the historical-record checks in the version-control section, and ask reviewers to justify their sampling of high-risk masters.
Q.Can a batch started under an older revision finish after a newer revision becomes effective?+
Possibly; use the transition assessment in the version-control section. Consider a revision correcting an excessive ingredient charge. If dispensing has not begun, reviewers can assess the corrected charge before material is used. If the charge is already blended, switching instructions cannot undo it; assess the affected material and investigate. This risk-based example differs from a formatting-only change. Capture the batch-specific rationale in the recipe supersession log.
Q.How can confidential sub-formulas be referenced without losing a reconstructable batch history?+
Apply the controls in the version-control section. For confidential sub-formulas, agree who can retrieve composition and execution evidence, under what authorization, and how access survives supplier changes. Test batch execution history from a parent batch to each consumed sub-batch or supplied lot, including quantities and units. If reviewers reach a proprietary code without access to supporting records, resolve that gap. Confidentiality should allow authorized reconstruction without granting every operator unrestricted formula access.
Primary sources
- 21 CFR 211.186 — Master production and control records
- 21 CFR 211.188 — Batch production and control records
- 21 CFR 111.205 — Dietary supplements: master manufacturing record requirement
- 21 CFR 111.210 — Dietary supplements: master manufacturing record contents
- 21 CFR 211.100 — Written procedures; deviations
- 21 CFR 211.180 — Records and reports: general requirements
- EudraLex Vol 4 Part I Chapter 4 — Documentation
- 21 CFR 11.1 — Part 11 scope
Explore this topic
MMR sits inside this topic cluster in our glossary. Every neighbour is one click away.
Master and executed records that prove a batch or device was made to spec.
Want to see how MMR could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.
